Skip to content

Immunization Services Model for Adult Rate Improvement

Immunization Services Model for Adult Rate Improvement

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02609035
Acronym
ImmuSMART
Enrollment
22301
Registered
2015-11-20
Start date
2016-03-31
Completion date
2017-03-31
Last updated
2017-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immunization, Pharmacy, Vaccines

Brief summary

ImmuSMART is a study of personalized telephonic prompts to community pharmacy patients to improve adult vaccination rates for pneumococcal and herpes zoster vaccines.

Detailed description

This study will investigate immunization rate improvement among adult patients in 250 northeastern US community pharmacies as a result of telephonic prompts during regular automated outbound communiqués. There will be three projects assessing different forms of these appended prompts-appointment-based medication synchronization automated prompts, refill ready automated prompts, and refill reminder automated prompts. Each intervention will occur in one of three pharmacy chains, each with approximately 10,000 patients randomized to control or intervention (receive prompt or no). Prior to the outbound automated call to the patient, a third-party technology vendor (Scientific Technologies Corporation) will perform an automated immunization status assessment of the patient by submitting a query the state immunization registry to compare the adult patient's existing immunization record to the CDC Recommended Adult Immunization Schedule. Gaps in immunizations that fall within pharmacy scope of practice will be identified. During the automated call (performed by VoicePort, a pharmacy telephonic support vendor) to the patient, they will be prompted to receive identified immunization gap vaccines upon their next pharmacy visit, with priority on pneumococcal, influenza, and herpes zoster vaccinations. If the patient accepts, the vaccination will be delivered when next the patient comes to visit the pharmacy. After 6 months of running the trial, statistical modeling will be employed to assess vaccination rate differences between control and intervention patients.

Interventions

BEHAVIORALTelephonic prompt

Sponsors

Pharmacy Quality Alliance
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient at least 19 years of age at date of enrollment * Patient not in long-term care, hospice or otherwise identified as unable to come to pharmacy for receipt of vaccine * Patient currently missing a record of receipt of at least one of three vaccinations: flu, pneumonia, or shingles * Patient enrolled in telephonic pharmacy reminder service

Design outcomes

Primary

MeasureTime frameDescription
Vaccination rates3 monthsAdministration of vaccine will be assessed at 3 months after patient receives the prompt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026